Profile

Markus Kiess

Dr Markus Kiess is the Business Director of the GMI, with management responsibility for all financial and administrative matters. 

Background

Dr Markus Kiess joined the GMI as Business Director in 2009. Previously he was Business Unit Head at Novartis Pharma Schweiz AG in Berne, Switzerland. Dr Kiess has a science background, holding a PhD degree in Molecular Biology, and has extensive business expertise, having completed advanced business training at both Harvard University and the St Gallen Business School.

Nationality

Swiss

Academic Qualifications

  • MSc: Biochemistry, Federal Institute of Technology (ETH) Zürich, Switzerland, 1989
  • PhD: Cancer Research, University of Zurich, Switzerland, 1993

Current and Former Positions

  • Research fellow (Postdoc) at the Department of Molecular and Cellular Pathology, University of Toronto, Canada (1993-1995)
  • Research scientist at the Institute for Neuropathology at the University Hospital of Zürich, Switzerland (1995-1996)
  • Clinical Trials Manager with Essex Chemie AG (Schering-Plough Inc.) in Lucerne, Switzerland (1996-1997)
  • Several positions at Novartis Pharma Schweiz AG in Berne, Switzerland (1997-2009):
  • Medical Marketing Manager (1997-2001)
  • Business Unit Head (including Infectious Diseases, Transplantation & Immunology), member of the executive board (2001-2009)

Awards, Honors & Fellowships

  • Fellowship, Swiss National Science Foundation (1993-1994)
  • Fellowship, Swiss Cancer League (1994-1995)
  • Cancer Research Award of the Dr. Arnold U. und Susanne Huggenberger-Bischoff Foundation (1995)

Gregor Mendel Institute of
Molecular Plant Biology GmbH


Dr. Bohr-Gasse 3
1030 Vienna, Austria

T: +43 1 79044-9000
F: +43 1 79044-9001
E: office(at)gmi.oeaw.ac.at

TRAVEL DIRECTIONS
LEGAL NOTICE

The Vienna Biocenter in the third district of Vienna has established itself as the premier location for life sciences in Central Europe and is a world-leading international bio-medical research center.

 

Visit the Website